One versus 2 years of alendronate following denosumab: the CARD extension. Tsai JN, Jordan M, Lee H, Leder BZ, et al. Osteoporos Int 2024;35:2225-2230.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsai JN, Jordan M, Lee H, Leder BZ, et al. One versus 2 years of alendronate following denosumab: the CARD extension. Osteoporos Int 2024;35:2225-2230.
PMID: 39112628